THE CRITERIA THAT CHANGE AFTER YOU ALREADY HAVE IT
I have hypermobile Ehlers-Danlos syndrome. hEDS. Chronic pain, joint instability, multisystem involvement. I've had it my whole life. The diagnosis came later – years of symptoms, specialists, tests, the long process of ruling out everything else before landing on the thing the medical system barely recognizes.
The Ehlers-Danlos Society just announced they're publishing updated classification criteria December 2, 2026, in the American Journal of Medical Genetics Part C (The Ehlers-Danlos Society, 2026). New diagnostic framework. Harvard Medical School and Brigham and Women's Hospital are partnering on models for earlier recognition in primary care, coordinated specialist referrals, better management (The Ehlers-Danlos Society, 2026). The goal is to reduce diagnostic delays and improve patient care.
That's good news. It is. Except I already have the diagnosis. So do tens of thousands of others. And the question nobody's asking is: what happens to us when the criteria change?
The prevalence nobody sees
One in 500 people. That's the prevalence estimate for hEDS and hypermobility spectrum disorders (The Ehlers-Danlos Society). One in 500. Not rare. Common enough that most primary care doctors should recognize it. But they don't, because the conditions remain "poorly understood and inconsistently diagnosed."
I knew something was wrong for decades before I had a name for it. Joints that dislocate. Chronic pain that doesn't fit the standard injury patterns. Fatigue that compounds. Skin that bruises and tears easily. Gastrointestinal issues, autonomic dysfunction, the cascade of secondary complications that come from connective tissue that doesn't hold the way it's supposed to.
The diagnostic delay is measured in years, sometimes decades. You go through rounds of specialists who tell you it's nothing, it's in your head, it's just anxiety, you're too young for this much pain. You get diagnosed with a dozen separate conditions – hypermobility, chronic pain syndrome, fibromyalgia, POTS, IBS – each treated in isolation, nobody connecting the underlying cause. And then, if you're lucky and persistent and have access to the right kind of specialist, you finally get a name for what you've been living with all along.
That's where I am. Diagnosed. Living with it. Managing it the best I can with the tools available.
What changing criteria means
Diagnostic criteria are supposed to identify what exists. They're the framework clinicians use to recognize a condition, differentiate it from similar presentations, confirm diagnosis, guide treatment. In theory, updating criteria makes them more accurate – better able to catch cases that were missed, more precise in distinguishing subtypes, aligned with current research.
In practice, changing criteria can reclassify people who already have a diagnosis. The new framework might be stricter. It might raise the threshold for what counts. It might redefine subtypes in ways that move someone from "hypermobile EDS" to "hypermobility spectrum disorder" – different name, different recognition, potentially different access to treatment and benefits.
I don't know yet what the December 2, 2026 criteria will say. The EDS Society hasn't published them. The peer review process is still ongoing. But I know what's at stake, because I've already lived through the diagnostic process once, and I know how much depends on meeting criteria that were written without input from the people who have the condition.
Insurance coverage hinges on diagnosis codes. Disability benefits require documented proof of functional limitations tied to recognized medical conditions. Workplace accommodations under the ADA need medical justification. Access to specialists, treatment protocols, pain management – all of it flows from having a diagnosis that the system recognizes as legitimate.
If the new criteria are stricter and I no longer meet them, does my hEDS disappear? No. The connective tissue dysfunction doesn't care what the criteria say. The pain doesn't stop because a committee decided the threshold should be higher. But the recognition does. The accommodations do. The insurance coverage does. The disability benefits do.
That's the gap. The condition is real. The criteria are a tool for recognition. When the tool changes, the condition stays the same, but the system's willingness to acknowledge it can vanish.
Earlier recognition doesn't help the people who already waited
The Harvard and Brigham partnership is focused on earlier primary care recognition. That's the right goal. Getting diagnosed earlier means less time spent in the diagnostic wilderness, fewer years of untreated symptoms compounding into secondary conditions, earlier access to management strategies that can prevent some of the worst downstream effects.
But earlier recognition for future patients doesn't do anything for the people who already spent decades getting here. We already have the diagnosis. We already lived through the delay. The damage from years of untreated joint instability, chronic pain, autonomic dysfunction – that's already done. Earlier recognition for the next generation doesn't undo what we went through to get recognized in the first place.
And if the new criteria reclassify us out of the diagnosis we finally got, then the delay starts over. We're back to proving something the medical system should have recognized years ago, only now we're doing it against a framework that might not account for the presentation we actually have.
Science catching up is not validation
When research updates diagnostic criteria to better reflect what people with a condition actually experience, that's not validation. It's correction. The condition was always there. The people living with it were always real. The criteria were incomplete.
Updating them to match reality is the medical system admitting it didn't get it right the first time. That's necessary. It's progress. But it doesn't validate the lived experience of people who were told for years that what they were feeling wasn't real, wasn't serious, wasn't worth investigating.
I have hEDS. I had it before the diagnosis. I'll have it after the criteria update. The question is whether the system will still recognize it, and whether that recognition will continue to open the doors to treatment, accommodations, and support – or whether I'll be back to proving all over again that what I've been living with my entire life is actually happening.
The updated criteria publish December 2, 2026. I'll be watching.
